BCL11A was reported to show restricted expression in fetal liver, bone marrow, lymphoid, and brain tissue [16,17], but our results clearly demonstrated that the proto-oncogene BCL11A was actively expressed in NSCLC. This evidence concerns the gene BCL11A and non-small cell lung carcinoma.